Pristanic acid
Suppliers
Names
[ CAS No. ]:
1189-37-3
[ Name ]:
Pristanic acid
[Synonym ]:
(2S,6R,10R)-2,6,10,14-tetramethylpentadecanoic acid
Pristaninsaeure
acide pristanique
Pristanic acid solution
2,6,10,14-Tetramethyl-pentadecansaeure
2,6,10,14-tetramethylpentadecanoic
acido pristanico
2,6,10,14-Tetramethylpentadecanoic acid
2,6,10,14-tetramethyl-pentadecanoic acid
MFCD05664739
Chemical & Physical Properties
[ Density]:
0.882g/cm3
[ Boiling Point ]:
408ºC at 760 mmHg
[ Molecular Formula ]:
C19H38O2
[ Molecular Weight ]:
298.50400
[ Flash Point ]:
14ºC
[ Exact Mass ]:
298.28700
[ PSA ]:
37.30000
[ LogP ]:
6.14620
[ Appearance of Characters ]:
ethanol solution
[ Vapour Pressure ]:
8.48E-08mmHg at 25°C
[ Index of Refraction ]:
1.453
[ Storage condition ]:
−20°C
MSDS
Safety Information
[ Symbol ]:
GHS02, GHS07
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H225-H319
[ Precautionary Statements ]:
P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235
[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
F: Flammable;
[ Risk Phrases ]:
R11
[ Safety Phrases ]:
S7
[ RIDADR ]:
UN 1170 3/PG 2
[ WGK Germany ]:
1
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
Biochim. Biophys. Acta 1853(1) , 111-25, (2014)
Peroxisomes are ubiquitous organelles which participate in a variety of essential biochemical pathways. An intimate interrelationship between peroxisomes and mitochondria is emerging in mammals, where...
J. Clin. Invest. 83(3) , 771-7, (1989)
Peroxisomal function was evaluated in a male infant with clinical features of neonatal adrenoleukodystrophy. Very long chain fatty acid levels were elevated in both plasma and fibroblasts, and beta-ox...
Cancer Epidemiol. Biomarkers Prev. 12(8) , 775-83, (2003)
An enzyme previously identified as alpha-methylacyl-CoA racemase (AMACR) is overexpressed in high-grade prostatic intraepithelial neoplasia and in a majority (60-100%) of prostate cancers (CaPs) as co...